eFFECTOR Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of eFFECTOR Therapeutics generated cash of -$29,550,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,233,000 last year. Net change in cash is therefore $6,167,000.
Cash Flow
| 2019 | -27.59M | 84K | 20.24M |
|---|---|---|---|
| 2020 | 13.83M | -154K | -1.89M |
| 2021 | -24.88M | 565K | 58.80M |
| 2022 | -25.89M | -17.86M | 2.76M |
| 2023 | -29.55M | 14.48M | 21.23M |
EFTRW Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 8.70M | 49.70M | 15.21M | 3.42M | 0 |
Operating activities | |||||
Net income | -35.81M | -22.66M | 15.79M | 14.21M | -29.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 111K | 53K | 24K | 160K | 307K |
Stock-based compensation expense | 4.59M | 5.33M | 8.66M | 499K | 646K |
| Deferred income tax benefit | 4.59M | 5.33M | 8.66M | 499K | 646K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 855K | 958K | 155K | -251K | -727K |
Cash generated by operating activities | -29.55M | -25.89M | -24.88M | 13.83M | -27.59M |
Investing activities | |||||
Purchases Of Investments | -17.16M | -52.41M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -97K | -192K | -42K | -154K | -4K |
Acquisitions Net | 0 | 17.66M | 607K | 0 | 88K |
Cash generated by investing activities | 14.48M | -17.86M | 565K | -154K | 84K |
Financing activities | |||||
Common Stock Issued | 21.17M | 2.79M | 56K | 108K | 20.32M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -86K |
Repayments of term debt | 0 | 0 | -13.94M | -2M | 0 |
Cash used in financing activities | 21.23M | 2.76M | 58.80M | -1.89M | 20.24M |
Net Change In Cash | 6.16M | -40.99M | 34.48M | 11.78M | 3.42M |
Cash at end of period | 14.87M | 8.70M | 49.70M | 15.21M | 3.42M |
| Data source | Data source | Data source | Data source |